MXCT vs PHM · rev $38.6M vs P/E 7.7, rev $17.95B
MaxCyte Inc (MXCT) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported PHM revenue for 2024-12-31 was $17.95B. Net income was $3.08B. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
MXCT currently screens at market cap $124.3M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the MXCT and PHM stock pages for the full models.
Not investment advice.